Articles

Is Zomedica Stock Worth the Risk? Unfortunately It’s Complicated

Zomedica started selling its TRUFORMA vet diagnostic system in March, but ZOM stock won’t see upside until supplier assay issues are resolved. More 

7 Busted Biotech Stocks Due for a Rebound

Buying biotech stocks while they're down is rewarding once they post positive clinical results, setting the stage for a big rally. More 

Make the Most of This Temporary Dip In Nio Stock

With strategic partnerships for expansion, Nio is making the right moves in the EV industry. NIO stock is a buy in the dip. More 

It’s Time to Let Original Bark Out of the Doghouse, Already

The post-IPO performance of BARK stock has been dismal, but there's a ripe opportunity here - not just for dog lovers, but all investors. More 

ISUN Stock: The Deal That Has Solar Play iSun Heating Up Today

Isun (ISUN) stock is shining brighter on Wednesday following news of a deal with SunCommon that will expand its business. More 

PATH Stock: 13 Things to Know as UiPath Shares Slump Today

UiPath (PATH) stock is falling hard on Wednesday following the release of its earnings report for the second quarter of fiscal 2022. More 

Only Rivian Thinks It’s Worth $80 Billion

The Rivian IPO will be made to a market that has grown skeptical of the electric vehicle future, and has already been burned by it. More